Effect of the SCL16A11 Risk Haplotype on Treatments to Prevent Type 2 Diabetes
Clinical trial NCT05990205 · COMPLETED
Trial details
- NCT number
- NCT05990205
- Sponsor
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-17
- Primary completion
- 2023-12-20
- Enrollment
- 437
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.